XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     116,323       116,323  
Beginning balance $ 1,388,107 $ 1,381,388 $ 1,353,422 $ 2,052,415 $ 2,095,502 $ 2,021,934 $ 1,353,422 $ 2,021,934
Net income 81,949 97,316 114,891 225,798 348,185 270,348 $ 294,156 844,331
Foreign currency adjustments (14,891) (6,536) 2,477 (49,790) (33,596) 6,870    
Dividends declared (73,724) (73,577) (73,581) (69,552) (71,506) (72,542)    
Stock issued for employee benefit plans 7,476 15,206 (375) 37,028 20,886 8,904    
Stock-based compensation expense $ 15,667 6,035 15,607 25,811 27,929 24,606    
Repurchase of common stock   (31,725) (31,053) (544,149) (334,985) (164,618)    
Ending balance (in shares) 116,465           116,465  
Ending balance $ 1,404,584 $ 1,388,107 $ 1,381,388 $ 1,677,561 $ 2,052,415 $ 2,095,502 $ 1,404,584 $ 1,677,561
Dividends declared, per share (in dollars per share) $ 0.61 $ 0.61 $ 0.61 $ 0.55 $ 0.55 $ 0.55    
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares) 116,335 116,437 116,323 125,116 128,011 129,186 116,323 129,186
Beginning balance $ 11,633 $ 11,644 $ 11,632 $ 12,512 $ 12,801 $ 12,919 $ 11,632 $ 12,919
Stock issued for employee benefit plans (in shares) 130 228 430 555 316 418    
Stock issued for employee benefit plans $ 14 $ 22 $ 44 $ 56 $ 31 $ 42    
Stock-based compensation expense (in shares) 0 0 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares)   (330) (316) (5,077) (3,211) (1,593)    
Repurchase of common stock   $ (33) $ (32) $ (509) $ (320) $ (160)    
Ending balance (in shares) 116,465 116,335 116,437 120,594 125,116 128,011 116,465 120,594
Ending balance $ 11,647 $ 11,633 $ 11,644 $ 12,059 $ 12,512 $ 12,801 $ 11,647 $ 12,059
Additional Paid-in Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 734,244 730,363 743,288 709,163 680,857 673,628 743,288 673,628
Stock issued for employee benefit plans (2,411) (2,154) (28,532) (3,478) 377 (17,377)    
Stock-based compensation expense 15,667 6,035 15,607 25,811 27,929 24,606    
Ending balance 747,500 734,244 730,363 731,496 709,163 680,857 747,500 731,496
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 5,655,489 5,631,750 5,590,440 5,411,346 5,134,667 4,936,861 5,590,440 4,936,861
Net income 81,949 97,316 114,891 225,798 348,185 270,348    
Dividends declared (73,724) (73,577) (73,581) (69,552) (71,506) (72,542)    
Ending balance 5,663,714 5,655,489 5,631,750 5,567,592 5,411,346 5,134,667 5,663,714 5,567,592
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (92,919) (86,383) (88,860) (87,860) (54,264) (61,134) (88,860) (61,134)
Foreign currency adjustments (14,891) (6,536) 2,477 (49,790) (33,596) 6,870    
Ending balance (107,810) (92,919) (86,383) (137,650) (87,860) (54,264) (107,810) (137,650)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (4,920,340) (4,905,986) (4,903,078) (3,992,746) (3,678,559) (3,540,340) (4,903,078) (3,540,340)
Stock issued for employee benefit plans 9,873 17,338 28,113 40,450 20,478 26,239    
Stock-based compensation expense 0 0 0 0 0 0    
Repurchase of common stock   (31,692) (31,021) (543,640) (334,665) (164,458)    
Ending balance $ (4,910,467) $ (4,920,340) $ (4,905,986) $ (4,495,936) $ (3,992,746) $ (3,678,559) $ (4,910,467) $ (4,495,936)